News Image

Exploring ABBOTT LABORATORIES (NYSE:ABT)s quality characteristics.

By Mill Chart

Last update: Mar 5, 2024

In this article we will dive into ABBOTT LABORATORIES (NYSE:ABT) as a possible candidate for quality investing. Investors should always do their own research, but we noticed ABBOTT LABORATORIES showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.

A Deep Dive into ABBOTT LABORATORIES's Quality Metrics.

  • ABBOTT LABORATORIES has shown strong performance in revenue growth over the past 5 years, with a 5.58% increase. This indicates the company's ability to generate consistent revenue growth and reflects its potential for long-term success.
  • With a robust ROIC excluding cash and goodwill at 29.04%, ABBOTT LABORATORIES showcases its effective allocation of capital and operational excellence. This metric signifies the company's ability to generate attractive returns and supports its long-term financial performance.
  • With a Debt/Free Cash Flow Ratio of 2.9, ABBOTT LABORATORIES exhibits solid financial health and responsible debt management practices. This ratio indicates the company's ability to generate ample free cash flow to meet its debt obligations and pursue growth opportunities.
  • With a robust Profit Quality (5-year) ratio of 115.0%, ABBOTT LABORATORIES highlights its ability to consistently generate high-quality profits. This metric reflects the company's effective management and operational excellence in delivering reliable earnings over the long term.
  • With a robust 5-year EBIT growth of 12.5%, ABBOTT LABORATORIES showcases its ability to consistently expand its operating profitability. This trend indicates the company's effective cost management and revenue generation strategies.
  • ABBOTT LABORATORIES has achieved superior EBIT 5-year growth compared to its Revenue 5-year growth. This demonstrates the company's ability to maximize its profitability through effective cost management and operational strategies.

A complete fundamental analysis of NYSE:ABT

As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.

Taking everything into account, ABT scores 7 out of 10 in our fundamental rating. ABT was compared to 196 industry peers in the Health Care Equipment & Supplies industry. ABT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABT is not valued too expensively and it also shows a decent growth rate.

For an up to date full fundamental analysis you can check the fundamental report of ABT

More quality stocks can be found in our Caviar Cruise screen.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

ABBOTT LABORATORIES

NYSE:ABT (4/26/2024, 4:37:29 PM)

After market: 107.74 +0.21 (+0.2%)

107.53

+0.67 (+0.63%)

ABT News

News Image7 hours ago - Market News VideoABT July 19th Options Begin Trading
News Image3 days ago - InvestorPlaceDividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes

It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.

News Image4 days ago - InvestorPlace3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip

These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.

News Image7 days ago - Investor's Business DailyStock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review

The Nasdaq and S&P 500 tumbled below their 50-day lines.

News Image9 days ago - Market News VideoWednesday Sector Laggards: Healthcare, Technology & Communications
News Image9 days ago - Market News VideoNoteworthy Wednesday Option Activity: LULU, ABT, AIG
News Image9 days ago - The Motley FoolAbbott Laboratories (ABT) Q1 2024 Earnings Call Transcript

ABT earnings call for the period ending March 31, 2024.

News Image9 days ago - ChartmillLet's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

News Image9 days ago - Market News VideoSee Which Of The Latest 13F Filers Holds Abbott Laboratories
News Image9 days ago - InvestorPlaceABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024

ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image9 days ago - BusinessInsiderABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Abbott Laboratories (NYSE:ABT) just reported results for the first quarter of 2...

News Image9 days ago - Investor's Business DailyAbbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report

Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but shares fell.

ABT Links
Follow us for more